tiprankstipranks
Trending News
More News >
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market

Bolt Biotherapeutics (BOLT) Income Statement

Compare
214 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q4 2024), Bolt Biotherapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Bolt Biotherapeutics's net income was $-15.94M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.69M$ 7.88M$ 5.73M$ 1.26M$ 231.00K
Gross Profit
$ 7.69M$ 5.99M$ 838.00K$ -2.41M$ -40.13M
Operating Expenses
$ 80.74M$ 84.07M$ 96.05M$ 94.05M$ 49.41M
Depreciation and Amortization
$ 1.78M$ 1.85M$ 4.89M$ 3.67M$ 2.50M
EBITDA
$ -66.45M$ -74.34M$ -88.66M$ -91.59M$ -48.57M
Operating Income
$ -73.05M$ -76.20M$ -90.32M$ -92.79M$ -49.18M
Other Income/Expenses
$ 9.93M$ 7.00M$ 2.22M$ -5.80M$ -11.55M
Pretax Income
$ -63.12M$ -69.20M$ -88.10M$ -98.59M$ -60.73M
Net Income
$ -63.12M$ -69.20M$ -85.88M$ -104.39M$ -72.27M
Per Share Metrics
Basic EPS
$ -1.65$ -1.83$ -2.30$ -2.79$ -1.99
Diluted EPS
$ -1.65$ -1.83$ -2.30$ -2.79$ -1.99
Weighted Average Shares Outstanding
38.18M 37.81M 37.36M 37.40M 36.25M
Weighted Average Shares Outstanding (Diluted)
38.18M 37.81M 37.36M 37.40M 36.25M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis